Department of Genetics, Washington University School of Medicine, St. Louis, MO.
Department of Biostatistics, University of Washington, Seattle, WA.
Nicotine Tob Res. 2018 Mar 6;20(4):448-457. doi: 10.1093/ntr/ntx107.
Genetic variants associated with nicotine dependence have previously been identified, primarily in European-ancestry populations. No genome-wide association studies (GWAS) have been reported for smoking behaviors in Hispanics/Latinos in the United States and Latin America, who are of mixed ancestry with European, African, and American Indigenous components.
We examined genetic associations with smoking behaviors in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) (N = 12 741 with smoking data, 5119 ever-smokers), using ~2.3 million genotyped variants imputed to the 1000 Genomes Project phase 3. Mixed logistic regression models accounted for population structure, sampling, relatedness, sex, and age.
The known region of CHRNA5, which encodes the α5 cholinergic nicotinic receptor subunit, was associated with heavy smoking at genome-wide significance (p ≤ 5 × 10-8) in a comparison of 1929 ever-smokers reporting cigarettes per day (CPD) > 10 versus 3156 reporting CPD ≤ 10. The functional variant rs16969968 in CHRNA5 had a p value of 2.20 × 10-7 and odds ratio (OR) of 1.32 for the minor allele (A); its minor allele frequency was 0.22 overall and similar across Hispanic/Latino background groups (Central American = 0.17; South American = 0.19; Mexican = 0.18; Puerto Rican = 0.22; Cuban = 0.29; Dominican = 0.19). CHRNA4 on chromosome 20 attained p < 10-4, supporting prior findings in non-Hispanics. For nondaily smoking, which is prevalent in Hispanic/Latino smokers, compared to daily smoking, loci on chromosomes 2 and 4 achieved genome-wide significance; replication attempts were limited by small Hispanic/Latino sample sizes.
Associations of nicotinic receptor gene variants with smoking, first reported in non-Hispanic European-ancestry populations, generalized to Hispanics/Latinos despite different patterns of smoking behavior.
We conducted the first large-scale genome-wide association study (GWAS) of smoking behavior in a US Hispanic/Latino cohort, and the first GWAS of daily/nondaily smoking in any population. Results show that the region of the nicotinic receptor subunit gene CHRNA5, which in non-Hispanic European-ancestry smokers has been associated with heavy smoking as well as cessation and treatment efficacy, is also significantly associated with heavy smoking in this Hispanic/Latino cohort. The results are an important addition to understanding the impact of genetic variants in understudied Hispanic/Latino smokers.
先前已鉴定出与尼古丁依赖相关的遗传变异,主要在欧洲血统人群中发现。在美国和拉丁美洲的西班牙裔/拉丁裔人群中,尚未有关于吸烟行为的全基因组关联研究(GWAS)报道,这些人群的混合祖先是欧洲人、非洲人和美洲原住民的混合体。
我们使用 ~230 万个经全基因组关联研究(GWAS)鉴定为 1000 基因组计划第三阶段的基因分型变体,对 12741 名具有吸烟数据的西班牙裔社区健康研究/拉丁裔研究(HCHS/SOL)参与者(5119 名曾经吸烟者)进行了与吸烟行为相关的遗传关联分析。混合逻辑回归模型考虑了人口结构、抽样、相关性、性别和年龄。
在比较 1929 名每日吸烟量(CPD)> 10 支的曾吸烟者与 3156 名 CPD ≤ 10 支的曾吸烟者时,已知编码α5 胆碱能烟碱受体亚单位的 CHRNA5 区域与重度吸烟达到全基因组显著水平(p ≤ 5×10-8)。CHRNA5 中的功能变体 rs16969968 的 p 值为 2.20×10-7,其次要等位基因(A)的优势比(OR)为 1.32;其次要等位基因频率总体为 0.22,且在不同的西班牙裔/拉丁裔背景群体中相似(中美洲裔为 0.17;南美洲裔为 0.19;墨西哥裔为 0.18;波多黎各裔为 0.22;古巴裔为 0.29;多米尼加裔为 0.19)。20 号染色体上的 CHRNA4 达到了 p < 10-4,支持了非西班牙裔人群中的先前发现。对于西班牙裔/拉丁裔吸烟者中常见的非每日吸烟,与每日吸烟相比,染色体 2 和 4 上的位点达到了全基因组显著水平;由于西班牙裔/拉丁裔样本量较小,复制尝试受到限制。
尼古丁受体基因变异与吸烟的关联,首先在非西班牙裔欧洲血统人群中报道,尽管吸烟行为模式不同,但在西班牙裔/拉丁裔人群中也具有普遍性。
我们对美国西班牙裔/拉丁裔人群进行了首次大规模全基因组关联研究(GWAS),也是首次对任何人群进行每日/非每日吸烟的 GWAS。结果表明,在非西班牙裔欧洲血统吸烟者中,与重度吸烟以及戒烟和治疗效果相关的烟碱受体亚单位基因 CHRNA5 区域,也与该西班牙裔/拉丁裔人群中的重度吸烟显著相关。这些结果对于理解在研究较少的西班牙裔/拉丁裔吸烟者中遗传变异的影响是重要的补充。